{"id":"https://openalex.org/W4391604246","doi":"https://doi.org/10.1016/j.jtct.2023.12.037","title":"Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) with R/R MCL: Subgroup Analyses in Pts with High-Risk Disease Features from the MCL Cohort of the TRANSCEND NHL 001","display_name":"Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) with R/R MCL: Subgroup Analyses in Pts with High-Risk Disease Features from the MCL Cohort of the TRANSCEND NHL 001","publication_year":2024,"publication_date":"2024-02-01","ids":{"openalex":"https://openalex.org/W4391604246","doi":"https://doi.org/10.1016/j.jtct.2023.12.037"},"language":"en","primary_location":{"id":"doi:10.1016/j.jtct.2023.12.037","doi":"https://doi.org/10.1016/j.jtct.2023.12.037","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2023.12.037","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jtct.2023.12.037","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052659722","display_name":"Maria Lia Palomba","orcid":"https://orcid.org/0000-0001-5099-9156","observed_orcids":["https://orcid.org/0000-0001-5099-9156"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M. Lia Palomba","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005565037","display_name":"Tanya Siddiqi","orcid":"https://orcid.org/0000-0001-5292-8298","observed_orcids":["https://orcid.org/0000-0001-5292-8298"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanya Siddiqi","raw_affiliation_strings":["City of Hope National Medical Center, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope National Medical Center, Duarte, CA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010130956","display_name":"Leo I. Gordon","orcid":"https://orcid.org/0000-0003-1666-7064","observed_orcids":["https://orcid.org/0000-0003-1666-7064"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leo I. Gordon","raw_affiliation_strings":["Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000537427","display_name":"Manali Kirtikumar Kamdar","orcid":"https://orcid.org/0000-0002-1930-152X","observed_orcids":["https://orcid.org/0000-0002-1930-152X"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manali Kamdar","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088179815","display_name":"Matthew Alexander Lunning","orcid":"https://orcid.org/0000-0002-2761-7612","observed_orcids":["https://orcid.org/0000-0002-2761-7612"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Lunning","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043131622","display_name":"Alexandre V. Vinaud Hirayama","orcid":"https://orcid.org/0000-0001-7980-3882","observed_orcids":["https://orcid.org/0000-0001-7980-3882"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre V Hirayama","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002103749","display_name":"Jeremy S. Abramson","orcid":"https://orcid.org/0000-0001-8467-9257","observed_orcids":["https://orcid.org/0000-0001-8467-9257"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy S. Abramson","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016770040","display_name":"Jon E. Arnason","orcid":"https://orcid.org/0000-0001-9038-7277","observed_orcids":["https://orcid.org/0000-0001-9038-7277"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon Arnason","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074766331","display_name":"Nilanjan Ghosh","orcid":"https://orcid.org/0000-0002-3848-6136","observed_orcids":["https://orcid.org/0000-0002-3848-6136","https://orcid.org/0000-0002-7217-243X"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nilanjan Ghosh","raw_affiliation_strings":["Atrium Health, Levine Cancer Institute, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health, Levine Cancer Institute, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030631799","display_name":"Amitkumar Mehta","orcid":"https://orcid.org/0000-0003-0537-4207","observed_orcids":["https://orcid.org/0000-0003-0537-4207"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amitkumar Mehta","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068715900","display_name":"Charalambos Babis Andreadis","orcid":"https://orcid.org/0000-0003-4681-6227","observed_orcids":["https://orcid.org/0000-0003-4681-6227"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charalambos Andreadis","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006999192","display_name":"Scott R. Solomon","orcid":"https://orcid.org/0000-0003-2061-8126","observed_orcids":["https://orcid.org/0000-0003-2061-8126"]},"institutions":[{"id":"https://openalex.org/I101890099","display_name":"Northside Hospital","ror":"https://ror.org/01g63ab19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I101890099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott R. Solomon","raw_affiliation_strings":["Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA","institution_ids":["https://openalex.org/I101890099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106623548","display_name":"Ana Kosti\u0107","orcid":"https://orcid.org/0000-0002-1975-6110","observed_orcids":["https://orcid.org/0000-0002-1975-6110"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Kostic","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113114253","display_name":"Ashvin Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashvin Singh","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029530100","display_name":"Ricardo Espinola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo Espinola","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108117554","display_name":"Lily H. Peng","orcid":"https://orcid.org/0009-0007-5552-5428","observed_orcids":["https://orcid.org/0009-0007-5552-5428"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lily Peng","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059141673","display_name":"Ken Ogasawara","orcid":"https://orcid.org/0000-0002-4264-8927","observed_orcids":["https://orcid.org/0000-0002-4264-8927"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ken Ogasawara","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075505073","display_name":"Amy M. Chattin","orcid":"https://orcid.org/0009-0000-1099-1678","observed_orcids":["https://orcid.org/0009-0000-1099-1678"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Chattin","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100438316","display_name":"Michael L. Wang","orcid":"https://orcid.org/0000-0001-9748-5486","observed_orcids":["https://orcid.org/0000-0001-9748-5486"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Wang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":16,"corresponding_author_ids":["https://openalex.org/A5052659722"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.4827,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.62309406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"30","issue":"2","first_page":"S14","last_page":"S14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisocabtagene-maraleucel","display_name":"lisocabtagene maraleucel","score":0.9520000219345093},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.906000018119812},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8309999704360962},{"id":"https://openalex.org/keywords/high-risk-features","display_name":"high-risk features","score":0.7310000061988831},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9769999980926514},{"id":"https://openalex.org/keywords/ki-67-proliferation-index","display_name":"Ki-67 proliferation index","score":0.9950000047683716},{"id":"https://openalex.org/keywords/blastoid-morphology","display_name":"blastoid morphology","score":0.9819999933242798},{"id":"https://openalex.org/keywords/secondary-cns-lymphoma","display_name":"secondary CNS lymphoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/complex-karyotype","display_name":"complex karyotype","score":0.7110000252723694},{"id":"https://openalex.org/keywords/btk-inhibitor-resistance","display_name":"BTK inhibitor resistance","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.734000027179718},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7699999809265137},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9010000228881836},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.46000000834465027},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.3709999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6353788375854492},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5903887748718262},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5190578103065491},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4462248682975769},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4288572072982788},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.42497915029525757},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.060045331716537476}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jtct.2023.12.037","doi":"https://doi.org/10.1016/j.jtct.2023.12.037","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2023.12.037","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jtct.2023.12.037","doi":"https://doi.org/10.1016/j.jtct.2023.12.037","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2023.12.037","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389246598","https://openalex.org/W4380081053","https://openalex.org/W4386332213","https://openalex.org/W4400109288","https://openalex.org/W2954529696","https://openalex.org/W7162542774","https://openalex.org/W7204732048","https://openalex.org/W4407976286","https://openalex.org/W4389527245","https://openalex.org/W3095832065"],"abstract_inverted_index":{"In":[0,415],"R/R":[1,50,55,421,463],"MCL,":[2],"several":[3],"high-risk":[4,34,205,424,466],"features":[5,35,206],"are":[6,475],"associated":[7],"with":[8,49,204,259,263,278,283,309,324,340,354,386,399,420,433,442,462],"a":[9,79,286,301,410,454,468],"worse":[10],"prognosis":[11],"including":[12,64,418],"TP53":[13,179,240,279,310],"mutation,":[14,241],"high":[15,264,270],"Ki-67":[16,165,171,234],"proliferation":[17],"index,":[18],"blastoid":[19,193,245],"morphology,":[20,246],"and":[21,72,106,126,168,181,190,195,218,253,269,272,335,369,375,394,423,437,465],"secondary":[22,116,226,325,387],"CNS":[23,227,326,388],"involvement.":[24],"We":[25],"report":[26],"outcomes":[27],"from":[28,36],"prespecified":[29],"subgroup":[30,416],"analyses":[31,417],"based":[32],"on":[33],"the":[37,260,292,355,383,443],"MCL":[38,56,422,464],"cohort":[39],"of":[40,45,61,82,122,130,154,306,337,363],"TRANSCEND":[41],"NHL":[42],"001":[43],"(NCT02631044)":[44],"liso-cel":[46,77,426,459],"in":[47,317,343,460],"pts":[48,132,203,224,277,282,308,323,339,385,419,461],"MCL.":[51],"Pts":[52,75],"had":[53,164,170,178,192,208,219,225,285,391,396,409,449],"PET-positive":[54],"after":[57,93],"\u2265":[58,166,235,402,412],"2":[59],"lines":[60,153],"prior":[62,151,216],"therapy,":[63],"Bruton":[65],"tyrosine":[66],"kinase":[67],"inhibitor":[68],"(BTKi),":[69],"alkylating":[70],"agent,":[71],"CD20-targeted":[73],"agent.":[74],"received":[76,133],"at":[78,320,346],"target":[80],"dose":[81],"50":[83],"\u00d7":[84,88],"106":[85,89],"or":[86,405],"100":[87],"CAR+":[90],"T":[91],"cells":[92],"lymphodepleting":[94],"chemotherapy.":[95],"Bridging":[96],"therapy":[97,155,213],"was":[98,138,145,156,329,333,351],"allowed.":[99],"Primary":[100],"endpoints":[101,117],"were":[102,257,316,342,367,379,439],"treatment-emergent":[103],"AEs":[104],"(TEAE)":[105],"ORR":[107,328],"by":[108],"independent":[109],"review":[110],"committee":[111],"(IRC;":[112],"Lugano":[113],"2014":[114],"criteria);":[115],"included":[118],"CR":[119,267,331,341],"rate,":[120,268],"duration":[121],"response":[123,319,345],"(DOR),":[124],"PFS,":[125,252],"OS.":[127],"A":[128],"total":[129],"88":[131],"liso-cel.":[134],"Median":[135,143,150],"on-study":[136],"follow-up":[137],"16.1":[139],"mo":[140],"(range,":[141,148,158],"0.4\u201360.5).":[142],"age":[144],"68.5":[146],"y":[147],"36\u201386).":[149],"systemic":[152],"3":[157,336,395,403,413],"1\u201311).":[159],"Among":[160,322,360],"liso-cel\u2013treated":[161],"pts,":[162],"75%":[163],"30%":[167,173],"17%":[169],"<":[172],"(not":[174,199],"reported,":[175,188,200],"8%),":[176],"23%":[177],"mutation":[180,280,284,311],"39%":[182],"did":[183,197],"not":[184,187,198],"(indeterminate,":[185],"5%;":[186],"34%),":[189],"31%":[191],"morphology":[194],"55%":[196],"15%).":[201],"Most":[202],"also":[207],"disease":[209],"refractory":[210],"to":[211,215,297],"last":[212],"and/or":[214],"BTKi":[217],"complex":[220],"karyotype.":[221],"Seven":[222],"(8%)":[223],"lymphoma":[228],"(refractory":[229],"disease,":[230],"n":[231,237,242,247],"=":[232,238,243,248],"5;":[233,239],"30%,":[236],"1;":[244],"1).":[249,275],"Response":[250],"rates,":[251],"OS":[254,273],"across":[255,349,431],"subgroups":[256,350,432,448],"consistent":[258,353,441],"overall":[261,293,356,444],"population,":[262,294],"ORR,":[265],"durable":[266,434],"PFS":[271],"(Table":[274,358],"Of":[276,382],"assessed,":[281],"numerically":[287],"lower":[288],"median":[289],"DOR":[290],"than":[291,303],"likely":[295],"due":[296],"more":[298],"responders":[299],"achieving":[300],"PR":[302],"CR.":[304],"However,":[305],"11":[307],"who":[312],"achieved":[313],"CR,":[314],"6":[315],"ongoing":[318,344],"cutoff.":[321,347],"lymphoma,":[327,389],"86%,":[330],"rate":[332],"71%,":[334],"5":[338,390],"Safety":[348],"generally":[352,440],"population":[357,469],"2).":[359],"subgroups,":[361],"TEAEs":[362],"special":[364],"interest":[365],"rates":[366],"similar,":[368],"most":[370],"cytokine":[371],"release":[372],"syndrome":[373],"(CRS)":[374],"neurological":[376],"events":[377],"(NE)":[378],"low":[380],"grade.":[381],"7":[384],"low-grade":[392,397],"CRS":[393,404],"NEs":[398],"no":[400],"grade":[401,411],"NEs;":[406],"1":[407],"pt":[408],"infection.":[414],"features,":[425,467],"showed":[427],"clinically":[428],"meaningful":[429],"efficacy":[430],"responses.":[435],"Efficacy":[436],"safety":[438],"population.":[445],"While":[446],"some":[447],"small":[450],"numbers,":[451],"results":[452],"suggest":[453],"favorable":[455],"benefit/risk":[456],"profile":[457],"for":[458,470],"whom":[471],"effective":[472],"treatment":[473],"options":[474],"rarely":[476],"available.":[477]},"counts_by_year":[{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-02-08T00:00:00"}